Thomas M. Burns's Net Worth
$2.81 Million
Who is Thomas M. Burns?
Thomas M. Burns has an estimated net worth of $2.81 Million. This is based on reported shares across multiple companies, which include XOMA Corp, and Acorda Therapeutics, Inc..
SEC CIK
Thomas M. Burns's CIK is 0001638479
Past Insider Trading and Trends
2020 was Thomas M. Burns's most active year for acquiring shares with 6 total transactions. Thomas M. Burns's most active month to acquire stocks was the month of October. 2017 was Thomas M. Burns's most active year for disposing of shares, totalling 12 transactions. Thomas M. Burns's most active month to dispose stocks was the month of October. 2020 saw Thomas M. Burns paying a total of $191,050.00 for 59,000 shares, this is the most they've acquired in one year. In 2020 Thomas M. Burns cashed out on 70,000 shares for a total of $1,222,301.76, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
XOMA Corp (XOMA) Snapshot price: $28.4
SVP, Finance & CFOThomas M. Burns owns 6,555 units of Common Shares which is worth $186,162.00, 6,555 units of Common Stock which is worth $186,162.00, 2,000 units of 8.625% Series A Cumulative Perpetual Preferred Stock which is worth $56,800.00 and 1,000 units of Depositary Shares - 8.375% B Cumulative Stock which is worth $28,400.00. In the year 2015 Thomas M. Burns acquired a total of 204,282 shares in XOMA Corp at a cost of $464,839.66, Thomas also disposed a total of 114,569 shares of XOMA Corp equalling to $2,820,500.01.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 8
| |||
Form 4
|
—
|
0
|
$17.85 | -$55,261.00 | 6.55K |
Scheduled
|
Jul 15
| ||
Form 4
|
—
|
0
|
$16.61 | -$364,663.59 | 6.55K |
Mar 21 - Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
∞
| 1K |
$25.00 | $25,000.00 | 1K |
Apr 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| +30.51% | 2K |
$27.96 | -$510,636.26 | 8.55K |
Scheduled
|
Dec 15
| ||
Form 4
|
—
|
0
|
$18.36 | -$343,947.63 | 6.55K |
Scheduled
|
Nov 20 - Nov 23
| ||
Form 4
|
—
|
0
|
$15.07 | -$176,667.88 | 6.55K |
Scheduled
|
Nov 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
$12.85 | -$141,146.65 | 6.55K |
Scheduled
|
Sep 18 - Sep 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
$15.11 | -$211,306.91 | 6.55K |
Apr 26 - Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
$16.36 | -$547,895.76 | 6.55K |
Nov 13 - Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| -28.38% | -2.60K |
$5.40 | -$14,029.98 | 6.55K |
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
| -9.51% | -19.25K |
$0.78 | -$15,104.69 | 183.07K |
Mar 22
| |||
Form 4
| +115.78% | 108.56K |
—
|
—
| 202.32K |
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acorda Therapeutics, Inc. (ACOR) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||